Literature DB >> 35478227

Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances.

Richard Z Zhuang1, Roberta Lock1, Bohao Liu2, Gordana Vunjak-Novakovic3,4,5.   

Abstract

Engineered human cardiac tissues facilitate progress in regenerative medicine, disease modelling and drug development. In this Perspective, we reflect on the most notable advances in cardiac tissue engineering from the past two decades by analysing pivotal studies and critically examining the most consequential developments. This retrospective analysis led us to identify key milestones and to outline a set of opportunities, along with their associated challenges, for the further advancement of engineered human cardiac tissues.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35478227     DOI: 10.1038/s41551-022-00885-3

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  150 in total

1.  Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.

Authors:  Christine Mummery; Dorien Ward-van Oostwaard; Pieter Doevendans; Rene Spijker; Stieneke van den Brink; Rutger Hassink; Marcel van der Heyden; Tobias Opthof; Martin Pera; Aart Brutel de la Riviere; Robert Passier; Leon Tertoolen
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

2.  Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.

Authors:  Johannes Riegler; Malte Tiburcy; Antje Ebert; Evangeline Tzatzalos; Uwe Raaz; Oscar J Abilez; Qi Shen; Nigel G Kooreman; Evgenios Neofytou; Vincent C Chen; Mouer Wang; Tim Meyer; Philip S Tsao; Andrew J Connolly; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Circ Res       Date:  2015-08-19       Impact factor: 17.367

3.  Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers.

Authors:  J Itskovitz-Eldor; M Schuldiner; D Karsenti; A Eden; O Yanuka; M Amit; H Soreq; N Benvenisty
Journal:  Mol Med       Date:  2000-02       Impact factor: 6.354

4.  Shortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue.

Authors:  Barry Fine; Gordana Vunjak-Novakovic
Journal:  ACS Biomater Sci Eng       Date:  2017-02-06

5.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

Authors:  I Kehat; D Kenyagin-Karsenti; M Snir; H Segev; M Amit; A Gepstein; E Livne; O Binah; J Itskovitz-Eldor; L Gepstein
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

6.  Modelling the long QT syndrome with induced pluripotent stem cells.

Authors:  Ilanit Itzhaki; Leonid Maizels; Irit Huber; Limor Zwi-Dantsis; Oren Caspi; Aaron Winterstern; Oren Feldman; Amira Gepstein; Gil Arbel; Haim Hammerman; Monther Boulos; Lior Gepstein
Journal:  Nature       Date:  2011-01-16       Impact factor: 49.962

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.

Authors:  Stefan R Braam; Leon Tertoolen; Anja van de Stolpe; Thomas Meyer; Robert Passier; Christine L Mummery
Journal:  Stem Cell Res       Date:  2009-12-03       Impact factor: 2.020

9.  Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.

Authors:  Florian Weinberger; Kaja Breckwoldt; Simon Pecha; Allen Kelly; Birgit Geertz; Jutta Starbatty; Timur Yorgan; Kai-Hung Cheng; Katrin Lessmann; Tomas Stolen; Marielle Scherrer-Crosbie; Godfrey Smith; Hermann Reichenspurner; Arne Hansen; Thomas Eschenhagen
Journal:  Sci Transl Med       Date:  2016-11-02       Impact factor: 17.956

Review 10.  Harnessing organs-on-a-chip to model tissue regeneration.

Authors:  Daniel Naveed Tavakol; Sharon Fleischer; Gordana Vunjak-Novakovic
Journal:  Cell Stem Cell       Date:  2021-06-03       Impact factor: 25.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.